Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications
Indian Journal of Pediatrics · 2025
DOI: 10.1007/s12098-024-05165-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pediatrics, 2025. Verfasst von Deepa Bhaskaran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Pediatrics, Child Development Centre, Thiruvananthapuram Medical College, Thiruvananthapuram, 695 011, Kerala, India. dee…. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Anticonvulsants, Epilepsy, Child Development. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
OBJECTIVES: To evaluate the effect of antiepileptic medications prescribed to mothers during pregnancy on the development and behavior of children. METHODS: From the Kerala Registry of Epilepsy and Pregnancy, 98 children between the ages of 1½ to 2½ y were consecutively chosen. Children of mothers who did not have epilepsy during pregnancy and not exposed to antiseizure medications (ASMs) antenatally were selected as comparator group. Developmental assessment of the children was performed using Developmental Assessment Scale for Indian Infants (DASII) and Receptive-Expressive Emergent Language Scale (REELS). Behavior outcomes were assessed using Child Behavior Checklist. RESULTS: A significant delay in expressive language skills was seen in children exposed to antiseizure medication with an odds ratio of 2.539 (95% CI 1.10, 5.85, P = 0.026). A delay in expressive language skills was seen in polytherapy with clobazam (odds ratio 6.83; 95% CI 2.17, 21.56, P < 0.001). Also, delay was seen in receptive language skills in the same polytherapy group (odds ratio of 7.333; 95% CI 2.16, 24.92, P < 0.001). There were no statistically significant differences between study and comparative groups in motor and mental quotient domains and behavioral outcomes. CONCLUSIONS: The finding of speech delay in children exposed to ASMs is significant since individuals with a history of childhood speech or language disorders may experience long-term difficulties in mental health, social well-being, and academic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Developmental Pediatrics, Child Development Centre, Thiruvananthapuram Medical College, Thiruvananthapuram, 695 011, Kerala, India. deepa.children@hotmail.com.
- Institute for Communicative and Cognitive Neurosciences (ICCONS), Thiruvananthapuram, Kerala, India.
- Child Development Centre, Thiruvananthapuram Medical College, Thiruvananthapuram, Kerala, India.
ORCID-Profile: Deepa Bhaskaran
Zitieren
APA
Bhaskaran, D., Thomas, S., & Scaria, L. M. (2025). Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian Journal of Pediatrics. https://doi.org/10.1007/s12098-024-05165-3
Vancouver
Bhaskaran D, Thomas S, Scaria LM. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications. Indian Journal of Pediatrics. 2025. doi:10.1007/s12098-024-05165-3
BibTeX
@article{Bhaskaran2025,
author = {Bhaskaran, Deepa and Thomas, Sanjeev and Scaria, Liss Maria},
title = {Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications},
journal = {Indian Journal of Pediatrics},
year = {2025},
doi = {10.1007/s12098-024-05165-3}
}
EUVIMED